Given the potential promise of TRAIL-based therapy and the problem of intrinsic resistance to TRAIL in melanoma, we sought to address the question of whether Wnt/β-catenin signaling could also sensitize melanoma cells to TRAIL-induced apoptosis. This evidence concerns the gene TNFSF10 and melanoma.